Ocular Therapeutix™ Reports First Quarter 2022 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Ocular Therapeutix (OCUL) Tops Q1 EPS by 4c
May 9, 2022 4:45 PM EDTOcular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.22), $0.04 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $14.2 million.
GUIDANCE:
Ocular Therapeutix sees Q2 2022 revenue of $55-60 million, versus the consensus of... More
